Is endogenous GLP-1 a major influence on the orbitofrontal cortex?

被引：2
作者：
May, Aaron A. [1 ]
Woods, Stephen C. [2 ]
机构：
[1] Univ Cincinnati, Metab Dis Inst, Coll Med, Dept Pathobiol & Mol Med, Cincinnati, OH 45237 USA
[2] Univ Cincinnati, Dept Psychiat, Metab Dis Inst, Coll Med, Cincinnati, OH 45237 USA
来源：
MOLECULAR METABOLISM | 2015年 / 4卷 / 12期
关键词：
D O I：
10.1016/j.molmet.2015.09.011
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：977 / 978
页数：2
相关论文
共 50 条
  • [21] Endogenous glucagon-like peptide (GLP)-1 as alternative for GLP-1 receptor agonists: Could this work and how?
    Smits, Mark M.
    Holst, Jens J.
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2023, 39 (08)
  • [22] Endogenous GLP-1 in lateral septum contributes to stress-induced hypophagia
    Terrill, Sarah J.
    Maske, Calyn B.
    Williams, Diana L.
    PHYSIOLOGY & BEHAVIOR, 2018, 192 : 17 - 22
  • [23] Pulmonary administration of GLP-1 (GLP-1 technosphere powder) II: Dynamics
    Costello, D.
    Baughman, R.
    Levy, B.
    van Vliet, A.
    Price, A.
    Diaz, M.
    Damico, C.
    Richardson, P.
    DIABETOLOGIA, 2008, 51 : S346 - S347
  • [24] GLP-1 treatment reduces endogenous insulin resistance via activation of central GLP-1 receptors in mice fed a high-fat diet
    Parlevliet, Edwin T.
    van Weenen, Judith E. de Leeuw
    Romijn, Johannes A.
    Pijl, Hanno
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2010, 299 (02): : E318 - E324
  • [25] Expression of GLP-1 Receptors in Insulin-Containing Interneurons of the Cerebral Cortex
    Csajbok, Eva
    Kocsis, Katalin
    Farago, Nora
    Brasko, Csilla
    Kovacs, Balazs
    Lovas, Sandor
    Puskas, Laszlo
    Liko, Istvan
    Patocs, Attila
    Tamas, Gabor
    DIABETES, 2017, 66 : LB74 - LB74
  • [26] The antagonistic metabolite of GLP-1, GLP-1 (9-36)amide, does not influence gastric emptying and hunger sensations in man
    Nagell, Carl Frederic
    Pedersen, Jan F.
    Holst, Jens J.
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2007, 42 (01) : 28 - 33
  • [27] GLP-1, GIP/GLP-1, and GCGR/GLP-1 receptor agonists: Novel therapeutic agents for metabolic dysfunction-associated steatohepatitis
    Singh, Anmol
    Sohal, Aalam
    Batta, Akash
    WORLD JOURNAL OF GASTROENTEROLOGY, 2024, 30 (48) : 5205 - 5211
  • [28] Brain GLP-1 and the regulation of food intake: GLP-1 action in the brain and its implications for GLP-1 receptor agonists in obesity treatment
    Trapp, Stefan
    Brierley, Daniel, I
    BRITISH JOURNAL OF PHARMACOLOGY, 2022, 179 (04) : 557 - 570
  • [29] Characterization of signal bias at the GLP-1 receptor induced by backbone modification of GLP-1
    Hager, Marlies V.
    Clydesdale, Lachlan
    Gellman, Samuel H.
    Sexton, Patrick M.
    Wootten, Denise
    BIOCHEMICAL PHARMACOLOGY, 2017, 136 : 99 - 108
  • [30] Topography of the GLP-1/GLP-1 receptor system in the spinal cord of male mice
    Ruska, Yvette
    Csibi, Andrea
    Doroghazi, Beata
    Szilvasy-Szabo, Anett
    Mohacsik, Petra
    Kornyei, Zsuzsanna
    Denes, Adam
    Kadar, Andrea
    Puskar, Zita
    Hrabovszky, Erik
    Gereben, Balazs
    Wittmann, Gabor
    Fekete, Csaba
    SCIENTIFIC REPORTS, 2024, 14 (01):
12345